Stopping randomized trials early for benefit: A protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

Matthias Briel, Melanie Lane, Victor M. Montori*, Dirk Bassler, Paul Glasziou, German Malaga, Elie A. Akl, Ignacio Ferreira-Gonzalez, Pablo Alonso-Coello, Gerard Urrutia, Regina Kunz, Carolina Ruiz Culebro, Suzana Alves da Silva, David N. Flynn, Mohamed B. Elamin, Brigitte Strahm, Mohammad Hassan Murad, Benjamin Djulbegovic, Neill K J Adhikari, Edward J. MillsFemida Gwadry-Sridhar, Haresh Kirpalani, Heloisa P. Soares, Nisrin O. Abu Elnour, John J. You, Paul J. Karanicolas, Heiner C. Bucher, Julianna F. Lampropulos, Alain J. Nordmann, Karen E A Burns, Sohail M. Mulla, Heike Raatz, Amit Sood, Jagdeep Kaur, Clare R. Bankhead, Rebecca J. Mullan, Kara A. Nerenberg, Per Olav Vandvik, Fernando Coto-Yglesias, Holger Schünemann, Fabio Tuche, Pedro Paulo M Chrispim, Deborah J. Cook, Kristina Lutz, Christine M. Ribic, Noah Vale, Patricia J. Erwin, Rafael Perera, Qi Zhou, Diane Heels-Ansdell, Tim Ramsay, Stephen D. Walter, Gordon H. Guyatt

*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Stopping randomized trials early for benefit: A protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)'. Together they form a unique fingerprint.

Medicine & Life Sciences